The primary factors contributing to the upregulation of PD-L1 can be attributed to a range of mechanisms, including (1) genomic abnormalities, (2) regulation by microRNAs, (3) activation of cancer-causing transcription factors and signaling pathways, and (4) post-translational modifications and trafficking. Here, CD274 is linked to cancer.